Status:
SUSPENDED
Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma
Lead Sponsor:
Azidus Brasil
Conditions:
Melasma
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The objective of this study is evaluating the clinical activity of the association (tretinoin + arbutin + triamcinolone) in the treatment of epidermal melasma.
Detailed Description
The melasma is a common hipermelanosis, acquired, symmetrical, with irregular occurring in areas such as photo-exposed face, forehead and temples, can affect the eyelids and tion. The facial regions m...
Eligibility Criteria
Inclusion
- Women adults aged more than 18 years;
- Patients suffering from melasma Epidermal the face of mild and moderate;
- Patients who have not done any treatment for melasma in the 3 months preceding the study;
- Patients with good mental and physical health;
- Patients who agree with the purposes of the study and sign the TCLE.
Exclusion
- Patients with skin diseases other than melasma, which interfere in clinical evaluation as hemangiomas and queloides;
- Patients with melasma skin or mixed;
- Patients with sensitivity to agents hipopigmentantes;
- Patients with sensitivity to fotoprotetores;
- Patients who are pregnant or breastfeeding;
- Patients who, at the discretion doctor, are not able to participate in the study;
- Patients who have carried out any treatment for melasma in the 3 months preceding the study
- Patients who do not agree with the terms described in the Statement of Informed Consent
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00717652
Start Date
July 1 2008
End Date
July 1 2008
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lal Clinica Pesquisa E Desenvolvimento Ltda
Valinhos, S, Brazil, 13270000